Katie Jaschke
Acute Care · Kansas City, KSNPI 1689024861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Boston Scientific at 42.7% of the total. Reporting peaked in 2024 at $2,521 and has fallen 78.2% since, to $549 in 2025. Among acute care clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $34.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$723
- Irhythm Technologies, Inc.$576
- Biosense Webster, Inc.$446
- Impulse Dynamics (USA) Inc.$204
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$197
- plus $847 from 18 others
What the payments were for
- Food & beverage$5,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 49 | $2,231 |
| Medtronic | 17 | $723 |
| Irhythm Technologies, Inc. | 21 | $576 |
| Biosense Webster, Inc. | 5 | $446 |
| Impulse Dynamics (USA) Inc. | 6 | $204 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $197 |
| Novo Nordisk | 8 | $175 |
| Novartis | 7 | $114 |
| Amgen | 6 | $110 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Pfizer | 4 | $71 |
| Merck | 3 | $55 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $46 |
| AstraZeneca | 3 | $42 |
| Abiomed | 1 | $23 |
| Atricure, Inc. | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Biobeat USA Inc. | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Biogen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,225 in reported general payments places this provider in the 90th percentile of 113 acute care providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Kansas City
- Jennifer WatkinsKansas City$23K
- Kristi DuchanoisKansas City$6K
- Abby BauerKansas City$3K
- Sara HenkelKansas City$2K
- Joseph NewmanKansas City$1K
- Jordan ShawKansas City$930
- Patrick StoffelKansas City$921
- Jean MitchellKansas City$849
- Morgan BinghamKansas City$547
- Eric AndrewKansas City$468
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.